Related references
Note: Only part of the references are listed.Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers
Stanislas Grassin-Delyle et al.
BRITISH JOURNAL OF ANAESTHESIA (2022)
Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial
Stanislas Grassin-Delyle et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study
Arnaud Lechien et al.
BLOOD COAGULATION & FIBRINOLYSIS (2021)
Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality A Systematic Review, Meta-analysis, and Meta-regression
Isabel Taeuber et al.
JAMA SURGERY (2021)
Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women
Homa K. Ahmadzia et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers
Zoe Kane et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Anatomical and physiological alterations of pregnancy
Jamil M. Kazma et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)
Plasma Concentrations of Tranexamic Acid in Postpartum Women After Oral Administration
Kopalasuntharam Muhunthan et al.
OBSTETRICS AND GYNECOLOGY (2020)
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
Roberto Picetti et al.
BLOOD COAGULATION & FIBRINOLYSIS (2019)
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial
Ian Roberts et al.
LANCET (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients
Angele Gayet-Ageron et al.
LANCET (2018)
A global view of severe maternal morbidity: moving beyond maternal mortality
Stacie E. Geller et al.
REPRODUCTIVE HEALTH (2018)
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
Haleema Shakur et al.
LANCET (2017)
Can she make it? Transportation barriers to accessing maternal and child health care services in rural Ghana
Kilian Nasung Atuoye et al.
BMC HEALTH SERVICES RESEARCH (2015)
Global causes of maternal death: a WHO systematic analysis
Lale Say et al.
LANCET GLOBAL HEALTH (2014)
Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss
K. Ker et al.
BRITISH JOURNAL OF SURGERY (2013)
Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2012)
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
Katharine Ker et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
Ian Roberts et al.
LANCET (2011)
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
Haleema Shakur et al.
LANCET (2010)
Share Paper
